A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
Titel:
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
Auteur:
Lin, Jianqing Zahurak, Marianna Beer, Tomasz M. Ryan, Charles J. Wilding, George Mathew, Paul Morris, Michael Callahan, Jennifer A. Gordon, Gilad Reich, Steven D. Carducci, Michael A. Antonarakis, Emmanuel S.